Skinvisible (SKVI) Equity Average (2011 - 2026)

Skinvisible has disclosed Equity Average across 16 years of filings, most recently posting -$10.4 million for Q1 2026.

• Equity Average for Q1 2026 came in at -$10.4 million, down 11.17% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.4 million (down 11.17% YoY), and the FY2025 annual result was -$9.7 million, down 6.79% from the prior year.
• Equity Average came in at -$10.4 million for Q1 2026 at Skinvisible, down from -$10.1 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of -$5.5 million in Q1 2022 to a low of -$10.4 million in Q1 2026.
• The 5-year median for Equity Average is -$9.2 million (2024), against an average of -$8.5 million.
• Across the five-year window, Equity Average plunged 44.84% in 2023 and retreated 1.59% in 2025, its largest moves.
• Skinvisible's Equity Average stood at -$6.4 million in 2022, then sank by 37.74% to -$8.9 million in 2023, then declined by 7.6% to -$9.5 million in 2024, then retreated by 6.16% to -$10.1 million in 2025, then slipped by 2.59% to -$10.4 million in 2026.
• The last three Equity Average figures came in at -$10.4 million (Q1 2026), -$10.1 million (Q4 2025), and -$9.9 million (Q3 2025), per Business Quant data.